Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues

scientific article

Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/J.1460-2075.1987.TB04855.X
P932PMC publication ID553499
P698PubMed publication ID3036488

P2093author name stringHowley PM
Baker CC
P2860cites workIdentification of the human papilloma virus-1a E4 gene productsQ24531494
Purification of Biologically Active Globin Messenger RNA by Chromatography on Oligothymidylic acid-CelluloseQ24563043
A new method for sequencing DNAQ24605576
Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseQ26778460
Studies on transformation of Escherichia coli with plasmidsQ27860598
Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomesQ27860600
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase IQ27860885
E5 open reading frame of bovine papillomavirus type 1 encodes a transforming geneQ28286988
A cDNA cloning vector that permits expression of cDNA inserts in mammalian cellsQ29614815
High-Efficiency Cloning of Full-Length cDNAQ29618285
The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoterQ29620405
Bovine papillomavirus type 1 3' early region transformation and plasmid maintenance functionsQ33928568
A bovine papillomavirus type 1-encoded modulator function is dispensable for transient viral replication but is required for establishment of the stable plasmid stateQ33929025
The L2 open reading frame of human papillomavirus type 1a encodes a minor structural protein carrying type-specific antigensQ33929781
Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequencesQ35358646
Translation of open reading frame E5 of bovine papillomavirus is required for its transforming activityQ35595257
Bovine papillomavirus contains multiple transforming genesQ36422987
Localization and analysis of bovine papillomavirus type 1 transforming functionsQ36895431
Fine structure of the cottontail rabbit papillomavirus mRNAs expressed in the transplantable VX2 carcinomaQ36898991
Genetic analysis of bovine papillomavirus type 1 trans-acting replication factorsQ36899614
Transcriptional organization of bovine papillomavirus type 1Q36907874
Complementation of a bovine papilloma virus low-copy-number mutant: evidence for a temporal requirement of the complementing geneQ36910968
Simian virus 40 major late promoter: an upstream DNA sequence required for efficient in vitro transcriptionQ36940690
Identification of a second transforming region in bovine papillomavirus DNAQ37580560
Bovine Papilloma Virus Transcription: Polyadenylated RNA Species and Assessment of the Direction of TranscriptionQ40141793
Transcription and DNA sequence of the BamHI L fragment of B95-8 Epstein-Barr virus.Q41571316
Differential regulation of papilloma virus early gene expression in transformed fibroblasts and carcinoma cell linesQ42223757
The primary structure and genetic organization of the bovine papillomavirus type 1 genomeQ42665433
Site-specific base substitution and deletion mutations that enhance or suppress transcription of the SV40 major late RNA.Q43821035
Characterization of the bovine papilloma virus plasmid maintenance sequencesQ45797228
Multiple Point Mutations Affecting the Simian Virus 40 EnhancerQ45799028
Virus-specific transcription in bovine papillomavirus-transformed mouse cellsQ45800470
Negative control of DNA replication in composite SV40-bovine papilloma virus plasmidsQ45836263
Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene productQ45838465
Messenger RNAs from the transforming region of bovine papilloma virus type I.Q45838602
Promoters and heterogeneous 5' termini of the messenger RNAs of adenovirus serotype 2.Q48409232
Multiple specific contacts between a mammalian transcription factor and its cognate promotersQ53747083
Dissociation of transforming and trans-activation functions for bovine papillomavirus type 1.Q54151145
Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNAQ59083203
Genetic analysis of the 3' early region transformation and replication functions of bovine papillomavirus type 1.Q64956444
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)1027-1035
P577publication date1987-04-01
P1433published inThe EMBO JournalQ1278554
P1476titleDifferential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues
P478volume6

Reverse relations

cites work (P2860)
Q36798097A bovine papillomavirus E1-related protein binds specifically to bovine papillomavirus DNA
Q36793349A bovine papillomavirus constitutive enhancer is negatively regulated by the E2 repressor through competitive binding for a cellular factor
Q36687296A constitutive enhancer in the bovine papillomavirus upstream regulatory region shares genetic elements with the viral P1 promoter
Q35882933A papillomavirus E2 phosphorylation mutant exhibits normal transient replication and transcription but is defective in transformation and plasmid retention
Q36825691Accumulation of RNA homologous to human papillomavirus type 16 open reading frames in genital precancers
Q40065013An E1M--E2C fusion protein encoded by human papillomavirus type 11 is asequence-specific transcription repressor
Q36820734An element in the bovine papillomavirus late 3' untranslated region reduces polyadenylated cytoplasmic RNA levels
Q35979296Analysis of HPV-1 E4 gene expression using epitope-defined antibodies
Q36295157Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells
Q33638736Bovine papilloma virus-transformed cells contain multiple E2 proteins
Q36889637Bovine papillomavirus transcriptional regulation: localization of the E2-responsive elements of the long control region
Q36881338Bovine papillomavirus type 1 E1 replication-defective mutants are altered in their transcriptional regulation
Q42612859Bovine papillomavirus type 1 E2 protein heterodimer is functional in papillomavirus DNA replication in vivo.
Q33292465Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB
Q35409389Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAs
Q37159116Bovine papillomavirus type 4 L1 gene transfection in a Drosophila S2 cell expression system: absence of L1 protein expression
Q36767326Cell-heritable stages of tumor progression in transgenic mice harboring the bovine papillomavirus type 1 genome
Q39857705Cellular factors are required to activate bovine papillomavirus-1 early gene transcription and to establish viral plasmid persistence but are not required for cellular transformation
Q42287823Characterisation of early and late bovine papillomavirus protein expression in equine sarcoids
Q36680070Characterization of the cis elements involved in basal and E2-transactivated expression of the bovine papillomavirus P2443 promoter
Q35226050Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function
Q67698418Comparison of neutralization of BPV-1 infection of C127 cells and bovine fetal skin xenografts
Q40663368Comparison of the basal and glucocorticoid-inducible activities of the upstream regulatory regions of HPV18 and HPV31 in multiple epithelial cell lines
Q34770066Differential expression of HPV16 L2 gene in cervical cancers harboring episomal HPV16 genomes: influence of synonymous and non-coding region variations
Q33847281Differentiation-dependent chromatin rearrangement coincides with activation of human papillomavirus type 31 late gene expression
Q35849203Differentiation-specific alternative splicing of bovine papillomavirus late mRNAs.
Q36652359Differentiation-specific expression from the bovine papillomavirus type 1 P2443 and late promoters
Q33853697Early polyadenylation signals of human papillomavirus type 31 negatively regulate capsid gene expression
Q39604102Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes
Q36917130Enhancers and trans-acting E2 transcriptional factors of papillomaviruses
Q36872236Evidence for cooperativity between E2 binding sites in E2 trans-regulation of bovine papillomavirus type 1.
Q36829530Genetic assignment of multiple E2 gene products in bovine papillomavirus-transformed cells
Q37078121Genetic modification of neural stem cells
Q42649713Genome of the European elk papillomavirus (EEPV).
Q36655698Hierarchy of polyadenylation site usage by bovine papillomavirus in transformed mouse cells.
Q37899326Human papillomavirus infections of the genital tract
Q33905805Human papillomavirus type 1 produces redundant as well as polycistronic mRNAs in plantar warts
Q36917086Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata
Q36650345Identification and characterization of novel promoters in the genome of human papillomavirus type 18.
Q35858861Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA
Q36792104Identification of bovine papillomavirus E1 mutants with increased transforming and transcriptional activity
Q36653942Importance of the bovine papillomavirus P2443 promoter in the regulation of E2 and E5 expression
Q36793417Induction of bovine papillomavirus E2 gene expression and early region transcription by cell growth arrest: correlation with viral DNA amplification and evidence for differential promoter induction.
Q33839721L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation
Q36697994Late promoter of human papillomavirus type 8 and its regulation
Q34348189Life cycle heterogeneity in animal models of human papillomavirus-associated disease
Q37071223Localization of bovine papillomavirus type 1 E5 protein to transformed basal keratinocytes and permissive differentiated cells in fibropapilloma tissue
Q36827496Loss of bovine papillomavirus DNA replication control in growth-arrested transformed cells.
Q34717843Messenger RNAs from the E1 region of bovine papillomavirus type 1 detected in virus-infected bovine cells
Q40562275Multiple cis-active elements in the long control region of bovine papillomavirus type 1 (BPV-1).
Q40448842Multiple cooperative interactions constrain BPV-1 E2 dependent activation of transcription
Q36636113Mutational analysis of human papillomavirus E4 proteins: identification of structural features important in the formation of cytoplasmic E4/cytokeratin networks in epithelial cells
Q35849102Mutational analysis of the 18-base-pair inverted repeat element at the bovine papillomavirus origin of replication: identification of critical sequences for E1 binding and in vivo replication
Q36920313Mutational analysis of the 3' open reading frames and the splice junction at nucleotide 3225 of bovine papillomavirus type 1.
Q36781513Numerous nuclear proteins bind the long control region of human papillomavirus type 16: a subset of 6 of 23 DNase I-protected segments coincides with the location of the cell-type-specific enhancer.
Q36781994Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms
Q36780194Open reading frames E6 and E7 of bovine papillomavirus type 1 are both required for full transformation of mouse C127 cells
Q33814170Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability
Q36801624Phenotypic analysis of bovine papillomavirus type 1 E2 repressor mutants
Q36829708Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia
Q36877486Promoters of bovine papillomavirus type 1: in vitro activity and utilization
Q42008115R-loop mapping of RNA transcripts from bovine papillomavirus type 4.
Q39036718Recent advances in preclinical model systems for papillomaviruses
Q40038156Regulation of DNA synthesis in division-arrested mouse C127 cells permissive for bovine papillomavirus DNA amplification
Q37125682Regulation of bovine papillomavirus type 1 gene expression by RNA processing
Q38332780Regulation of early gene expression from the bovine papillomavirus genome in transiently transfected C127 cells
Q33648895Regulation of human papillomavirus type 31 polyadenylation during the differentiation-dependent life cycle
Q36651655Repression of bovine papillomavirus type 1 transcription by the E1 replication protein.
Q37256346Role of papillomaviruses
Q35864749Selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site is regulated through an exonic splicing enhancer and its juxtaposed exonic splicing suppressor
Q36000905Sequence-specific and general transcriptional activation by the bovine papillomavirus-1 E2 trans-activator require an N-terminal amphipathic helix-containing E2 domain
Q36663019Sequences homologous to 5' splice sites are required for the inhibitory activity of papillomavirus late 3' untranslated regions
Q36548636Structural, functional, and protein binding analyses of bovine papillomavirus type 1 exonic splicing enhancers
Q36866660Study of the E2 gene product of the cottontail rabbit papillomavirus reveals a common mechanism of transactivation among papillomaviruses
Q33783002Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b.
Q41353765The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region
Q42631894The E2 protein of human papillomavirus type 16. Over-expression and purification of an active transcriptional regulator
Q36812512The E2 transactivator of bovine papillomavirus type 1 is expressed from multiple promoters.
Q42271216The E4 protein; structure, function and patterns of expression
Q40141212The E6-E7 region of human papillomavirus type 18 is sufficient for transformation of NIH 3T3 and rat-1 cells
Q36793464The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element
Q36989421The biology and significance of human papillomavirus infections in the genital tract.
Q36062091The bovine papillomavirus P2443 promoter is E2 trans-responsive: evidence for E2 autoregulation
Q33932448The bovine papillomavirus constitutive enhancer is essential for viral transformation, DNA replication, and the maintenance of latency
Q35977741The carboxy-terminal domain shared by the bovine papillomavirus E2 transactivator and repressor proteins contains a specific DNA binding activity
Q36638250The genomes of the animal papillomaviruses European elk papillomavirus, deer papillomavirus, and reindeer papillomavirus contain a novel transforming gene (E9) near the early polyadenylation site
Q36551242The human immunodeficiency virus type 1 Rev protein and the Rev-responsive element counteract the effect of an inhibitory 5' splice site in a 3' untranslated region
Q36831106The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes.
Q39549244The inhibitory activity of the AU-rich RNA element in the human papillomavirus type 1 late 3' untranslated region correlates with its affinity for the elav-like HuR protein.
Q26750643The reciprocal regulation between splicing and 3'-end processing
Q35977695The specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2-dependent enhancer
Q33929973The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones
Q34293109The viral E4 protein is required for the completion of the cottontail rabbit papillomavirus productive cycle in vivo
Q48230838Topical use of 5% acyclovir cream for the treatment of occult and verrucous equine sarcoids: a double-blinded placebo-controlled study.
Q33929980Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis
Q36830039Transcriptional termination between bovine papillomavirus type 1 (BPV-1) early and late polyadenylation sites blocks late transcription in BPV-1-transformed cells
Q68279933Tumor Progression in Transgenic Mice Containing the Bovine Papillomavirus Genome
Q33645669Two novel promoters in the upstream regulatory region of human papillomavirus type 31b are negatively regulated by epithelial differentiation
Q39336561Viral and cellular oncogenes in papillomavirus-associated cancers
Q69834669[Warts and viruses]
Q37509240tRNASer(CGA) differentially regulates expression of wild-type and codon-modified papillomavirus L1 genes

Search more.